In the last decades, Abs targeting the MOG protein and the water channel AQP4 have been identified in patients with inflammatory demyelinating disorders, defining clinically and immunologically distinct diseases from multiple sclerosis. The gene discussed is MOG; the disease is multiple sclerosis.